The bioavailability of these hormones firmly depends on sex hormone-binding globulin and it has been reported that hyperinsulinemia is responsible for reduction of concentration of the circulating sex hormone-binding globulin, therefore, it enhances the level of bioactive estrogen in diabetic female [16]. The gene discussed is SHBG; the disease is hyperinsulinism.